Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Terminated × Tissue Banks × Clear all

Phase

Phase NA 1 Phase 1 1

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 1

Interventions

Cyclophosphamide 88 pembrolizumab 69 Gemcitabine 66 fludarabine 55 Nivolumab 50 Carboplatin 48 Rituximab 44 Radiotherapy 44 Paclitaxel 42 Docetaxel 42 Cisplatin 42 Lenalidomide 37 Dexamethasone 36 Ipilimumab 34 Cytarabine 31 Radiation 29 Etoposide 28 Azacitidine 28 Temozolomide 27 venetoclax 25 Bevacizumab 25 Bortezomib 23 Pemetrexed 21 Capecitabine 21 fludarabine phosphate 20 Magnetic Resonance Spectroscopy 20 atezolizumab 19 Oxaliplatin 19 Interleukin-2 19 Everolimus 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04239040 2025-03-19

GVAX Plus Checkpoint Blockade in Neuroblastoma

Dana-Farber Cancer Institute

Phase 1 Terminated

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡